diabetestalk.net

GLP-1 Diabetes Drug Neutral For The Heart

GLP-1 Diabetes Drug Neutral for the Heart

GLP-1 Diabetes Drug Neutral for the Heart


GLP-1 Diabetes Drug Neutral for the Heart
-Once-weekly exenatide safe for CV outcomes but falls short of showing benefit
by Crystal Phend, Senior Associate Editor, MedPage Today 2017-09-14
This article is a collaboration between MedPage Today and:
LISBON -- Extended-release exenatide (Bydureon) was safe for the heart but didn't help prevent cardiovascular events in type 2 diabetes among a mixed primary and secondary prevention population, the EXSCEL trial showed.
For the primary composite endpoint of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke, the once-weekly GLP-1 diabetes drug fell just short of showing a cardiovascular benefit, Rury Holman, FRCP, of the Diabetes Trials Unit at the University of Oxford in England, and colleagues reported here at the European Association for the Study of Diabetes meeting and in a paper published simultaneously in the New England Journal of Medicine .
Note that this large, pragmatic randomized trial failed to demonstrate that extended release exenatide was superior to placebo in terms of cardiac outcomes among patients with type 2 diabetes.
This stands in contrast to trials with certain other agents in the GLP-1 class, which showed beneficial cardiovascular effects.
Rates for the composite after median follow-up of 3.2 years were 11.4% with the drug versus 12.2% with placebo (HR 0.91, 95% CI 0.83-1.00), each used along with usual care. That translated to noninferiority for safety (P<0.001 for noninferiority) but missed superiority for efficacy (P=0.06 for superiority), as had been annou Continue reading

Rate this article
Total 1 ratings
Abbott Secures Health Canada License for FreeStyle Libre System for People with Diabetes - Jun 29, 2017

Abbott Secures Health Canada License for FreeStyle Libre System for People with Diabetes - Jun 29, 2017


Abbott Secures Health Canada License for FreeStyle Libre System for People with Diabetes
- Revolutionary system eliminates the need for routine finger sticks1 and finger stick calibration
- Provides real-time glucose levels for up to 14 days
- Will be reimbursed by two major Canadian insurers; available in the coming months across Canada
ABBOTT PARK, Ill., June 29, 2017 / PRNewswire / -- Abbott (NYSE: ABT) today announced the Health Canada license of its FreeStyle Libre Flash Glucose Monitoring System, a revolutionary new glucose sensing technology for Canadian adults with diabetes. The first-of-its-kind system eliminates the need for routine finger sticks,1 requires no finger stick calibration, and reads glucose levels through a sensor that can be worn on the back of the upper arm for up to 14 days.
"The first word that came to mind when I learned about FreeStyle Libre was 'freedom'," said Maria Miclea, who has been managing her Type 1 diabetes for eight years. "Freedom from the pain of routine testing and from social awkwardness. Also, peace of mind, knowing that I can quickly and easily scan my glucose levels whenever and wherever I want to help better manage my diabetes."
With traditional glucose monitoring systems, people with diabetes often have to stick their finger a number of times throughout the day2,3 to test their glucose levels. With Abbott's FreeStyle Libre system, people now have a convenient, less painful alternative to get a glucose reading. The disposable sensor is worn on the back of the upper arm. The system measures glucose every minute in int Continue reading

Ghana ranks 6th on diabetes table in Africa

Ghana ranks 6th on diabetes table in Africa

Ghana has been ranked sixth among other Africa countries, according to statistics by the World Health Organisation (WHO) on diabetes between 2016 and 2017.
The Chairperson of International Diabetes Federation of West Africa, also President of National Diabetes Association of Ghana, Elizabeth Esi Denyoh, who made this known at the commemoration of the 2017 World Diabetes Day at Kyebi in the East Akim Municipality of the Eastern Region, explained that it is estimated that undiagnosed diabetes accounts for 60 percent of those with the disease in Cameroon, 70 percent in Ghana and over 80 percent in Tanzania.
She said Ghana, among other Africa countries, counts approximately 13.6 million people with diabetes, which includes sub-Saharan Africa counts over seven million people with diabetes.
According to her, Nigeria has the highest number of 1,218,000 diabetes cases, followed by Uganda and Tanzania.
Speaking further on the theme: ‘Women Unite Against Diabetes’, Mrs Denyoh appealed to the government to reverse the decision of the cancellation of VAT exemptions on all the diabetes drugs because of their high cost in order to enable patients to afford them.
She also called on parliament to take a look at introducing the ‘sin taxes’ to tax fizzy drinks, alcoholic beverages, sweets and cigarettes so that the proceeds would go into the care of non-communicable diseases.
199m Women Diabetics
Dr Charity Sarpong, Eastern Regional Director of Ghana Health Service, disclosed that over 199 million women are currently living with diabetes worldwide.
“This is projected to increase to Continue reading

Northern Ontario lacks diabetes resources

Northern Ontario lacks diabetes resources


Northern Ontario lacks diabetes resources
Thursday, November 23, 2017 3:56:04 EST AM
World Diabetes Day is Nov. 14 and the International Diabetes Federation encourages getting screened for type 2 diabetes to reduce the risk of complications. (Metro News Service)
NORTHERN ONTARIO - It could be dubbed a diabetes catch-22.
In pockets of Ontario where the disease is so prevalent, resources to treat and promote healthy lifestyles to nip some forms of diabetes in the bud are often most sparse.
So, if you're in downtown Toronto, you can probably get to a dietitian or diabetes educator who can advise you about your risk and help you get going on a lifestyle program Those resources are so much less available in the North, says Dr. Jan Hux, chief science officer for Diabetes Canada.
North East Local Health Integration Network (LHIN) figures have suggested that at least 12 per cent of Northeastern Ontarios population is affected by the often debilitating and sometimes fatal disease, compared to some 10 per cent of Ontarians. Statistics are even more staggering for those living along the Hudson Bay and James Bay coast, where some 24 per cent of the population lives with diabetes.
Many high-risk communities, where there are large pockets of low-income neighbourhoods, are often dogged with limited access to recreation opportunities.
They can't afford the gym membership, they can't afford the running shoes, they can't afford the babysitter, Hux told The Sault Star in an interview from Toronto. So, (opportunities) may be there, but they're not accessible to them.
About 90 Continue reading

A Practical Approach to Hypertension Management in Diabetes

A Practical Approach to Hypertension Management in Diabetes


, Volume 8, Issue5 , pp 981989 | Cite as
A Practical Approach to Hypertension Management in Diabetes
Hypertension is one of the most important comorbidities of diabetes, contributing significantly to death and disability and leads to macrovascular and microvascular complications. When assessing the medical priorities for patients with diabetes, treating hypertension should be a primary consideration. Practical approaches to hypertension in diabetes, including individualized targets are discussed, as per stage and complication of diabetes, according to current studies and guidelines. Angiotensin converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARBs) are the most effective drugs for treating hypertension in diabetes, in the absence of contraindications. Calcium antagonists or diuretics are acceptable as second-line agents. Once the target is achieved, antihypertensive drugs should be continued. Newer antidiabetes medications such as sodium glucose cotransporter-2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP1-RA), and dipeptidyl peptidase-4 inhibitors (DPP4i) have antihypertensive properties and may assist in treatment decision-making.
AntidiabeticAntihypertensiveAzilsartanDiabetes, DPP4GLP1RaHypertensionMacrovascularMicrovascularSGLT2
Hypertension is one of the most important comorbidities of diabetes [ 1 , 2 ], contributing significantly to death and disability [ 3 ]. It is responsible for macrovascular (atherosclerotic cardiovascular disease, peripheral arterial disease, stroke) and microvascular (retinopathy, neuropathy, nephr Continue reading

No more pages to load

Popular Articles

  • FREE Diabetes Testing and Healthy Heart Screenings

    Please see the schedule below for upcoming Healthcare Clinics including: Diabetes Testing and Healthy Heart Screenings • Our Diabetes Testing measures your A1C levels. Your A1C is a measure of your average blood sugar over the previous 3 months. This test requires only a small amount of blood and no fasting. • Our Healthy Heart screenings offer a risk assessment for heart disease, a lipid-stic ...

  • Poor Diet Linked to Half of Heart Disease, Stroke, Diabetes Deaths

    Most of us are aware that what we eat affects our health. But the results of a new study illustrates that fact vividly: Almost half of deaths in one year caused by heart disease, stroke and type 2 diabetes in a large group of Americans were linked with a poor diet. Researchers from Tufts University in Boston, the University of Cambridge in England and Montifiore Medical Center in New York analyzed ...

  • Diabetes and heart disease linked by genes, reveals Penn-led study

    PHILADELPHIA -- Type 2 diabetes (T2D) has become a global epidemic affecting more than 380 million people worldwide; yet there are knowledge gaps in understanding the etiology of type-2 diabetes. T2D is also a significant risk factor for coronary heart disease (CHD), but the biological pathways that explain the connection have remained somewhat murky. Now, in a large analysis of genetic data, publ ...

  • Does diabetes make a heart attack feel different?

    (Reuters Health) - People with diabetes may not always feel classic symptoms like acute chest pain when they have a heart attack, according to a small study that offers a potential explanation for why these episodes are more deadly for diabetics. Researchers examined data from detailed interviews with 39 adults in the UK who had been diagnosed with diabetes and had also experienced a heart attack. ...

  • Sugary drinks kill 184,000 a year through diabetes, heart disease and cancer

    Sugary soft drinks kill 184,000 adults every year, scientists claim. And there could be a ticking time bomb because those under 45 consume more artificially sweetened drinks and are more at risk of diabetes and obesity. The worldwide study is the first to estimate deaths and disability from diabetes, heart disease, and cancers caused by the drinks. It said 133,000 deaths from diabetes, 45,000 deat ...

  • Disease Prevention: Diabetes and Heart Problems Can Be Avoided if You Eat Slower

    Growing up, your parents probably delivered lectures about your eating habits, namely getting enough fruits and vegetables, not playing with your food, and not scarfing down the contents of your plate. Turns out, wise mom was right again when it comes to chewing thoroughly—the American Heart Association released new information that gobbling down your food could damage your heart and cause weigh ...

  • MTHFR, Diabetes, and Heart Disease

    Dr. Doni, author of The Stress Remedy, explains the connections between MTHFR mutations, diabetes, and heart disease, and offers tips for optimizing your health. Heart disease is the leading cause of death (above cancer), and diabetes is known to increase risk of heart disease. That amounts to over 600,000 deaths per year from heart disease1 and over $100 billion spent each year to address diabete ...

  • Increased heart rate and cardiovascular risk in hypertension and diabetes

    High resting heart rate increases the risk of cardiovascular morbidity and mortality in the general population, as well as in those with hypertension, and in those with type 2 diabetes. Drugs that increase the heart rate may adversely affect cardiovascular health Population studies have shown that there is a relationship between high resting heart rate and increased risk of cardiovascular events a ...

  • Too much sitting linked to heart disease, diabetes, premature death

    Like many people, I have a job that involves sitting in front of a computer most of the day. Because I work from home, I don’t have to sit through a long commute, and my dog gets me up out of my chair for walks a couple times a day. Still, a new study about the health hazards of sitting too much (or what researchers call sedentary behavior) has made me more conscious of how much uninterrupted ch ...

Related Articles